Top | S-Quatre Corporation

エディタV2

Power of child’s stem cells to Fight incurable diseases

お知らせ：表示

2025/04/15：S-Quatre to Present Novel Large-Scale Manufacturing Method for SQ-SHED at ISCT 2025: S-Quatre Corporation, a subsidiary of Kidswell Bio Corporation, today announced that Mr. Yamada, Director of the Manufacturing Development Department, will present a novel proprietary large-scale manufacturing method for SQ-SHED at the upcoming ISCT 2025 Annual Meeting, taking place in New Orleans, LA, USA, in May 7–10, 2025. The presentation will be delivered in collaboration with CORNING Incorporated, a global leader in cell culture technologies.

The newly developed method enables the efficient and scalable manufacturing of SQ-SHED, representing a significant advancement in the field of cell therapy. In line with this progress, S-Quatre has entered into a joint development agreement with NIPRO Corporation, one of the leading contract development and manufacturing organizations (CDMOs) in Japan, to further advance the process development for late-stage clinical trials and future commercial production.

About ISCT 2025
The International Society for Cell & Gene Therapy (ISCT) Annual Meeting is a premier global forum for cell therapy professionals, bringing together scientists, clinicians, and industry leaders to discuss the latest advancements in the field.
More information: https://www.isctglobal.org/annual-meeting/homepage

エディタV2

Aiming for the World's First Cell Therapy Using SHED

Research of regenerative medicine using various types of cells has been actively performed around the world. We focused on SHED “stem cells from a child’s tooth” and are strenuously conducting the research and development to realize a new cell therapeutics for various intractable diseases.

エディタV2

S-Quatre^® – Stable Manufacturing and Supply System of Cell Banks for Cell Therapeutics

Practical application of cell therapeutics needs to stably procure donor tissue sources, manufacture cell banks, and supply them. We established a stable manufacturing and supply system of SHED banks named S-Quatre^® by our own technology and network, composing a platform of the development of our cell therapeutics.